Effettuare il login Iscriviti gratis

Alkermes plc Q/Q di EPS

Cos'è Q/Q di EPS di Alkermes plc?

Q/Q di EPS di Alkermes plc è -85.71%

Qual è la definizione di Q/Q di EPS?



Il tasso di crescita trimestrale dell'utile, trimestre su trimestre , è l'aumento di EPS di un'azienda negli ultimi 4 trimestri rispetto alla performance dei precedenti 4 trimestri.

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Q/Q di EPS di aziende nel Health Care settore su NASDAQ rispetto a Alkermes plc

Cosa fa Alkermes plc?

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

Aziende con q/q di eps simili a Alkermes plc